Clinical Trials on Healthy Male Adult in United Kingdom

Total 16620 results

Eli Lilly and Company

Completed

A Study of LY3143753 and LY3185643 in Healthy Participants

Healthy

United Kingdom
Galapagos NV

Completed

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

Healthy

United Kingdom
University of Nottingham
University of Michigan; Food and Drug Administration (FDA)

Completed

In Vivo Predictive Dissolution 1 (iPD1)

Healthy

United Kingdom
Daiichi Sankyo, Inc.

Completed

Multiple Dose Study of DS-1971a

Healthy

United Kingdom
Daiichi Sankyo, Inc.

Completed

Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

Healthy

United Kingdom
Daiichi Sankyo, Inc.

Completed

Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a

Healthy

United Kingdom
Poxel SA

Completed

Effect of Cimetidine on the PK of Imeglimin

Healthy

United Kingdom
Corcept Therapeutics

Completed

CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

Healthy

United Kingdom
Janssen-Cilag International NV

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

Healthy

United Kingdom
Unilever R&D
University of Bristol Dental Hospital

Completed

Effect of a Toothpaste and Serum Compared to Standard Fluoride Toothpaste on Gingival Health Over a Six Month Period.

Healthy

United Kingdom
Alios Biopharma Inc.

Terminated

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

Healthy

United Kingdom
Takeda

Completed

TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants

Healthy

United Kingdom
Galen Limited

Completed

Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects

Healthy

United Kingdom
Eli Lilly and Company

Completed

A Study of LY3305677 in Healthy Participants

Healthy

United Kingdom
Pharmaero ApS

Completed

Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™

Healthy

United Kingdom
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers

Healthy

United Kingdom
King's College London

Unknown

Particle Sizing of Masticated Tree Nuts - Cashews and Walnuts

Healthy

United Kingdom
King's College London

Unknown

Particle Sizing of Masticated Tree Nuts - Pistachios and Brazils

Healthy

United Kingdom
University of Glasgow

Completed

Impact of Training Status on Bioavailability of Flavanones

Healthy

United Kingdom
Pronova BioPharma

Completed

Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects

Healthy

United Kingdom
AstraZeneca

Completed

Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

Healthy

United Kingdom
AstraZeneca

Completed

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069 (JSMAD)

Healthy

United Kingdom
Lupin Ltd.

Completed

A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects

Healthy

United Kingdom
Pronova BioPharma

Completed

Bioavailability of Omega-3 Food Supplements in Healthy Subjects

Healthy

United Kingdom
Pronova BioPharma

Completed

[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study

Healthy

United Kingdom
Galapagos NV

Completed

Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects

Healthy

United Kingdom
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese Participants

Healthy

United Kingdom
LEO Pharma

Completed

LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects

Healthy

United Kingdom
Sauflon Pharmaceuticals Ltd

Completed

Clinical Performance of All-in-One Light Multi-purpose for Silicone Hydrogel Contact Lenses

Healthy

United Kingdom
AstraZeneca

Completed

Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers (ADME)

Healthy

United Kingdom
AstraZeneca

Terminated

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551

Healthy

United Kingdom
AstraZeneca

Completed

Single and Multiple Ascending Doses of AZD1981 in Japan (JSAD/JMAD)

Healthy

United Kingdom
AstraZeneca

Completed

Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval

Healthy

United Kingdom
Solvay Pharmaceuticals

Completed

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

Healthy

United Kingdom
Solvay Pharmaceuticals

Completed

Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

Healthy

United Kingdom
AstraZeneca

Completed

AZD9056 Relative Bioavailability Study

Healthy

United Kingdom
Alexion Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults

Healthy

United Kingdom
ATXA Therapeutics Limited
Hammersmith Medicines Research

Recruiting

Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose

Healthy

United Kingdom
King's College London

Recruiting

Micronutrient Bioavailability From Wheat

Healthy

United Kingdom
Eli Lilly and Company

Recruiting

A Study of LY3873862 in Healthy Participants

Healthy

United Kingdom
Alexion Pharmaceuticals, Inc.
Celerion

Completed

Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants

Healthy

United Kingdom
Asceneuron S.A.
Hammersmith Medicines Research; Invicro

Completed

PET Study of Repeated ASN51 in Healthy Volunteers

Healthy

United Kingdom
Alexion Pharmaceuticals, Inc.

Terminated

A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants

Healthy

United Kingdom
Alexion Pharmaceuticals, Inc.

Completed

Pharmacokinetic Study of Ravulizumab Administered Subcutaneously With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult Volunteers

Healthy

United Kingdom
Kyorin Pharmaceutical Co.,Ltd

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects

Healthy

United Kingdom
Bellus Health Inc. - a GSK company

Completed

Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects

Healthy

United Kingdom
Alexion

Completed

Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults

Healthy

United Kingdom
Upstream Bio Inc.

Completed

Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

Healthy

United Kingdom
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck KGaA, Darmstadt, Germany

Completed

Study Comparing Pharmacokinetics of Different Formulations of Evobrutinib in Healthy Participants

Healthy

United Kingdom
Eli Lilly and Company

Completed

A Device Study in Healthy Participants

Healthy

United Kingdom

3

Subscribe